ストックスクリーナーアプリを入手
31.84
1.60%
0.50
アフターアワーズ：
31.84
前日終値:
$31.34
開ける：
$32.15
24時間の取引高:
1.26M
Relative Volume:
0.83
時価総額：
$1.64B
収益：
$190.41M
当期純損益:
$20.48M
株価収益率:
142.91
EPS:
0.2228
ネットキャッシュフロー:
$46.66M
1週間 パフォーマンス:
-2.93%
1か月 パフォーマンス:
-22.36%
6か月 パフォーマンス:
-49.23%
1年 パフォーマンス:
-36.38%
1日の値動き範囲:
$31.55
$33.45
1週間の範囲:
$30.11
$34.20
52週間の値動き範囲:
$30.11
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
名前
Soleno Therapeutics Inc
セクター
電話
650-213-8444
住所
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Compare SLNO vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
31.84 | 1.62B | 190.41M | 20.48M | 46.66M | 0.2228 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-18 | 開始されました | Wolfe Research | Outperform |
| 2025-10-07 | 開始されました | Goldman | Buy |
| 2025-08-20 | 開始されました | Wells Fargo | Overweight |
| 2025-06-23 | 開始されました | TD Cowen | Buy |
| 2025-03-05 | 再開されました | Stifel | Buy |
| 2024-12-02 | 繰り返されました | Robert W. Baird | Outperform |
| 2024-12-02 | 繰り返されました | Stifel | Buy |
| 2024-09-03 | 開始されました | H.C. Wainwright | Buy |
| 2024-05-10 | 開始されました | Robert W. Baird | Outperform |
| 2024-02-05 | 開始されました | Piper Sandler | Overweight |
| 2024-01-23 | 開始されました | Stifel | Buy |
| 2023-11-21 | 再開されました | Guggenheim | Buy |
| 2020-09-29 | 開始されました | Guggenheim | Buy |
| 2020-01-10 | 開始されました | Craig Hallum | Buy |
| 2019-12-23 | 開始されました | Oppenheimer | Outperform |
| 2018-02-13 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Soleno Therapeutics Inc (SLNO) 最新ニュース
ROSEN, HIGHLY REGARDED INVESTOR RIGHTS COUNSEL, Encourages Soleno Therapeutics, Inc. Investors ... - Bluefield Daily Telegraph
Soleno Therapeutics, Inc. (SLNO) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - The Globe and Mail
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
SLNO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) ... - Bluefield Daily Telegraph
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud - GuruFocus
Investors of Soleno Therapeutics, Inc. (NASDAQ: SLNO) Seeking RecoveryContact Kaplan Fox Before Deadline on May 5, 2026 - NewMediaWire
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application - GlobeNewswire
Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - GlobeNewswire Inc.
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Commercial Viability Risks: Levi & Korsinsky - Business Wire
Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman - PR Newswire
DEADLINE ALERT for BSX, EOSE, SLNO, and NKTR: The Law - GlobeNewswire
Soleno Therapeutics (NASDAQ:SLNO) Moves With Broader Nasdaq Index Decline - Kalkine Media
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
SLNO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Soleno Therapeutics, Inc. Securities Lawsuit -- The Gross Law Firm - PR Newswire
JPMorgan Chase & Co. Raises Stock Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) Sets New 1-Year LowWhat's Next? - MarketBeat
Robbins LLP Urges SLNO Stockholders Who Lost Money Investing in Soleno Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action - PR Newswire
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit - ChartMill
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities - GlobeNewswire
SLNO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Deadline Alert: Soleno Therapeutics, Inc. (SLNO) - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Soleno - GlobeNewswire
Soleno Therapeutics Faces Investor Lawsuit Over Alleged Safety Concealment in VYKAT XR Drug Launch - TipRanks
Soleno Therapeutics (SLNO) Faces Securities Class Action - GlobeNewswire
Notice to Long-Term Shareholders of ASP Isotopes Inc. - GlobeNewswire
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
A Look At Soleno Therapeutics (SLNO) Valuation After Oppenheimer’s Vykat XR Launch Outlook - Sahm
SLNO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 - Sahm
SLNO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Soleno - GlobeNewswire
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure ... - Caledonian Record
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO - GlobeNewswire Inc.
INVESTOR DEADLINE: Soleno Therapeutics Inc. (SLNO) - GlobeNewswire
Soleno Therapeutics (NASDAQ:SLNO) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
User - The Chronicle-Journal
Price-Driven Insight from (SLNO) for Rule-Based Strategy - Stock Traders Daily
Should Soleno’s Governance Shift, Vykat XR Launch Concerns and Lawsuit Require Action From Soleno Therapeutics (SLNO) Investors? - simplywall.st
Soleno Therapeutics Investors File Securities Fraud Lawsuit - National Today
Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc.SLNO - PR Newswire
SLNO SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on - GlobeNewswire
Soleno Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | 1SLNO | US8342033094 - marketscreener.com
NASDAQ: SLNO: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Soleno Therapeutics, Inc. - ChartMill
SLNO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Soleno Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SLNO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026 - TMX Newsfile
A Look At Soleno Therapeutics (SLNO) Valuation As Oppenheimer Updates Vykat XR Launch And 2026 Sales Outlook - Yahoo Finance
Soleno Therapeutics Sued for Securities Law Violations - National Today
Soleno Therapeutics, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsSLNO - Lelezard
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesSLNO - PR Newswire
Soleno Lawsuit Puts DCCR Safety Disclosures And Growth Story Under Scrutiny - simplywall.st
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure ... - Caledonian Record
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Soleno - GlobeNewswire
Soleno Therapeutics Inc (SLNO) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):